Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide plus 1 L PEG versus 2 L PEG for colonoscopy bowel preparation in low-risk adults
ChiCTR2100053273Phase 4Recruiting
- Sponsor
- Third People's Hospital of Chengdu
- Start
- Jan 2022
- Modality
- Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of linaclotide and macrogol in inadequate bowel preparation (IBP) (2 arms), sponsored by Third People's Hospital of Chengdu. Primary endpoints: Bowel preparation cleanliness score and Rate of adequate bowel preparation. Started Jan 2022; status: recruiting.
02
Drugs
linaclotidemacrogol
03
Conditions
inadequate bowel preparation (IBP)
Beyond the preview
Go deeper on ChiCTR2100053273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053273.